nivolumab
BMS
['nivo', 'improve ', 'nivolumab', 'renal,(-adrenal)', 'rcc,(-irccs),(-srcc),(-urcc)', 'prosper,trial']
prosper rcc clinical trial chair, , says trial shows neoadjuvant #nivolumab did not improve recurrence-free survival for #highriskrenalcellcarcinoma in patients studied. talk by 9/10 at #esmo22. 
Breaking news from JHM media relations, sharing mind-blowing stories about science, medicine, people & more. For media inquiries contact us at jhmedia@jhmi.edu